BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS

Karishma Rajani; Lucas P. Carlstrom; Joshua J. Jacobs; Mark A. Schroeder; Ian Olson; Matthew E Hainy; Juhee Oh; William F. Elmquist; Jann N. Sarkaria; Terry C. Burns

doi:https://doi.org/10.1093/noajnl/vdab024.019

doi.org/10.1093/noajnl/vdab024.019

BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS

,

,

..., Terry C. Burns

21

Neuro-oncology advances3.50

Volume: 3, Issue: Supplement_1, Pages: i5 - i5

Published: Mar 1, 2021

Abstract

Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system, with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant transformation of lower-grade isocitrate dehydrogenase (IDH) 1-mutant tumors. The unique metabolomic profile of IDH1-mutant tumors presents opportunities to...

Paper Fields

Paper Details

Title

BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS

DOI

doi.org/10.1093/noajnl/vdab024.019

Published Date

Mar 1, 2021

Journal

Neuro-oncology advances

Volume

3

Issue

Supplement_1

Pages

i5 - i5

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History